"Structure of the hepatitis C virus E1E2 glycoprotein complex" was co-authored by Alba Torrents de la Peña, Lisa Eshun-Wilson, Gabriel Lander, and Andrew Ward, of Scripps Research; Kwinten ...

The hepatitis C virus, or HCV, causes a chronic liver infection ... limited by uncertainty around what it looks like. Knowing the structure of the protein is necessary to figure out how the ...

Hepatitis B virus infections can progress from an acute ... approximately 74% base pairing to form an unbranched rod-like structure. The genome sequence shows no homology to the 3300-nucleotide ...

Hepatitis D virus more closely resembles viroids and virusoids than traditional RNA viruses: it is a small single-stranded circular RNA, it has a double-stranded rod-like secondary structure ...

where the virus replicates and then attempts to cause infection in other liver cells. This article discusses the structure of HBV, how it affects the body, and how to manage and prevent hepatitis ...

Exactly how hepatitis D virus manages to appropriate the host polymerases remains unclear, but it’s likely that its rod-like double-stranded structure confuses the cell into mistaking it for a ...

Panel A shows the structure of HDV, which shares the hepatitis B surface antigen (HBsAg) envelope with hepatitis B virus. The virion contains a single-stranded, circular RNA genome of ...

Each form of hepatitis starts with a virus. Vaccines can prevent hepatitis A and hepatitis B, but no vaccines have been developed to protect against the other three diseases. Children born after ...

Hepatitis B is a serious liver disease caused by the hepatitis B virus (HBV), which is a small DNA virus from the Hepadnaviridae family. If someone has this infection for a long time, it can lead ...

Discover 7 destructive ways hepatitis C attacks liver tissue. Learn how this viral infection progresses from inflammation to cirrhosis and liver failure.

While the virus was mostly eliminated from blood banks after its initial discovery in 1989, it continues to spread chiefly via needle-sharing among intravenous drug users in developed countries ...